Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?

被引:5
作者
Hirshfeld, E. [1 ]
Weiss, L. [1 ]
Kasir, J. [1 ]
Zeira, M. [1 ]
Slavin, S. [1 ]
Shapira, M. Y. [1 ]
机构
[1] Hebrew Univ Jerusalem, Ctr Med, Dept Bone Marrow Transplantat & Canc Immunotherap, IL-91120 Jerusalem, Israel
关键词
graft-versus-host disease; non-myeloablative; stem cell transplantation; chimerism; antigen presentation;
D O I
10.1038/sj.bmt.1705449
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Although the use of non-myeloablative stem cell transplantation (NST) reduces the severity of graft-versus-host disease (GVHD), GVHD remains a major complication following allogeneic transplantation. Since following NST in comparison with myeloablative conditioning, higher proportions of host immunohematopoietic cells may persist while donor-derived alloreactive lymphocytes are being infused, thus possibly serving as host antigen presentation for continuous stimulation of donor T cells, we speculated that GVHD may be similarly amplified by conditioning followed by intentional administration of host cells. This hypothesis was tested in a preclinical animal model. Increased incidence of GVHD, higher mortality and increased levels of chimerism were observed in recipients reconstituted with host cells, particularly with non-irradiated spleen cells. Graft-versus-leukemia effect was not impaired by post transplant cell administration. These results suggest that GVHD may be amplified by recipient cell infusion using either irradiated or viable stimulatory host cells, thus possibly explaining in part higher than anticipated incidence of GVHD and rapid displacement of host cells and conversion to 100% donor type cells following NST. Administration of irradiated host antigen-presenting cells post transplantation may thus represent a potential approach for ampli. cation of the alloreactive capacity of donor lymphocytes following stem cell transplantation.
引用
收藏
页码:359 / 364
页数:6
相关论文
共 28 条
[1]  
APPELBAUM FR, 1985, CANCER-AM CANCER SOC, V55, P2202, DOI 10.1002/1097-0142(19850501)55:9+<2202::AID-CNCR2820551424>3.0.CO
[2]  
2-S
[3]   Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers [J].
Bittencourt, MD ;
Perruche, S ;
Contassot, E ;
Fresnay, SP ;
Baron, MH ;
Angonin, R ;
Aubin, F ;
Hervé, P ;
Tiberghien, P ;
Saas, P .
BLOOD, 2001, 98 (01) :224-230
[4]  
BORANIC M, 1971, CANCER RES, V31, P1140
[5]   Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease [J].
Chan, GW ;
Gorgun, G ;
Miller, KB ;
Foss, FM .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (03) :170-176
[6]  
COHEN P, 1993, J IMMUNOL, V151, P4803
[7]   Acute and chronic Graft-versus-Host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation [J].
Couriel, DR ;
Saliba, RM ;
Giralt, S ;
Khouri, I ;
Andersson, B ;
de Lima, M ;
Hosing, C ;
Anderlini, P ;
Donato, M ;
Cleary, K ;
Gajewski, J ;
Neumann, J ;
Ippoliti, C ;
Rondon, G ;
Cohen, A ;
Champlin, R .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (03) :178-185
[8]   Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease [J].
Duffner, UA ;
Maeda, Y ;
Cooke, KR ;
Reddy, P ;
Ordemann, R ;
Liu, C ;
Ferrara, JLM ;
Teshima, T .
JOURNAL OF IMMUNOLOGY, 2004, 172 (12) :7393-7398
[9]   The immunopathophysiology of acute graft-versus-host disease [J].
Ferrara, JLM ;
Cooke, KR ;
Pan, LY ;
Krenger, W .
STEM CELLS, 1996, 14 (05) :473-489
[10]   Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy [J].
Giralt, S ;
Estey, E ;
Albitar, M ;
vanBesien, K ;
Rondon, G ;
Anderlini, P ;
OBrien, S ;
Khouri, I ;
Gajewski, J ;
Mehra, R ;
Claxton, D ;
Andersson, B ;
Beran, M ;
Przepiorka, D ;
Koller, C ;
Kornblau, S ;
Korbling, M ;
Keating, M ;
Kantarjian, H ;
Champlin, R .
BLOOD, 1997, 89 (12) :4531-4536